Report cover image

Global Antipsychotic Drugs Market Size, Trends & Growth Opportunity, By Therapeutic Class, By Application, By Distribution Channel, By region, and Forecast till 2027.

Publisher QualiKet Research
Published Dec 01, 2022
SKU # QUA17623954

Description

Global Antipsychotic Drugs Market Size, Trends & Growth Opportunity, By Therapeutic Class, By Application, By Distribution Channel, By region, and Forecast till 2027.

Global Antipsychotic Drugs Market

The Global Antipsychotic Drugs Market was valued at USD 14.54 Billion in 2021 and it is expected to reach USD 22.09 Billion by 2027 from, at a CAGR of 6.8% over the forecast period.

The research offers an analysis of the Global Antipsychotic Drugs Market, in which market size, growth rate, and overall attractiveness are assessed across component, application, end user, categories. The research includes both historical data and a revenue forecast. The study examines the Antipsychotic Drugs Market drivers and restraints, as well as their impact on demand, throughout the forecast period. Furthermore, the study examines the market's global opportunities.

The research contains a competitive landscape as well as an examination of Porter's Five Forces model for the industry. The research gives a current assessment of the present market situation, recent trends and drivers, and the overall market environment. The analysis includes worldwide and regional market estimations and assessments.

By segmenting the Global Antipsychotic Drugs Market by therapeutic class, application, distribution channel, and region, the report gives an in-depth overview of the market. All segments have been researched in light of current and prospective market trends. The report begins by describing the worldwide market's general scope, as well as the feasibility of investments in various market segments, before moving on to a descriptive section that describes the feasibility of new projects that may succeed in the global market in the near future.

Competitive Outlook:

The report's competitive landscape was created by taking into account all of the important factors, including business profiling, market share, recent developments and advancements, gross margins, product portfolio, revenue generation, financial status, market position, and expansion strategies. In addition, the research delves into recent mergers and acquisitions, joint ventures, collaborations, product launches and brand promotions, agreements, corporate and government deals, and partnerships, among other topics. The research also discusses the Global Antipsychotic Drugs Market's current technological innovations and product advancements.

Key Players:

The Key Players of Global Antipsychotic Drugs Market are Eli Lily and Company, AstraZeneca plc., GlaxoSmithKline plc., Johnson & Johnson, Otsuka Pharmaceutical Co, Ltd., Pfizer Inc., AbbVie Inc., Bristol-Myers Squibb, Teva Pharmaceuticals, and Dr. Reddy's Laboratories.

Market Taxonomy:

By Therapeutic Class

First-generation

Second-generation

By Application

Schizophrenia

Dementia

Bipolar disorder

Depression

Others

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Table of Contents

1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2. Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Applications
3. Executive Summary
4. Global Antipsychotic Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5. Global Antipsychotic Drugs Market, By Therapeutic Class
5.1 Y-o-Y Growth Comparison, By Therapeutic Class
5.2 Global Antipsychotic Drugs Market Share Analysis, By Therapeutic Class
5.3 Global Antipsychotic Drugs Market Size and Forecast, By Therapeutic Class
5.3.1 First-generation
5.3.2 Second-generation
6. Global Antipsychotic Drugs Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Antipsychotic Drugs Market Share Analysis, By Application
6.3 Global Antipsychotic Drugs Market Size and Forecast, By Application
6.3.1 Schizophrenia
6.3.2 Dementia
6.3.3 Bipolar disorder
6.3.4 Depression
6.3.5 Others
7. Global Antipsychotic Drugs Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Antipsychotic Drugs Market Share Analysis, By Distribution Channel
7.3 Global Antipsychotic Drugs Market Size and Forecast, By Distribution Channel
7.3.1 Hospital Pharmacies
7.3.2 Retail Pharmacies
7.3.3 Online Pharmacies
8. Global Antipsychotic Drugs Market, By Region
8.1 Global Antipsychotic Drugs Market Share Analysis, By Region
8.2 Global Antipsychotic Drugs Market Size and Forecast, By Region
8.3 Global Antipsychotic Drugs Market Size and Forecast, By Region
9. North America Antipsychotic Drugs Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Antipsychotic Drugs Market Share Analysis, By Therapeutic Class
9.3 North America Antipsychotic Drugs Market Size and Forecast, By Application
9.4 North America Antipsychotic Drugs Market Size and Forecast, By Distribution Channel
9.5 North America Antipsychotic Drugs Market Size and Forecast, By Country
9.5.1 US
9.5.2 Canada
9.5.3 Mexico
10. Europe Antipsychotic Drugs Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Antipsychotic Drugs Market Share Analysis, By Therapeutic Class
10.3 Europe Antipsychotic Drugs Market Size and Forecast, By Application
10.4 Europe Antipsychotic Drugs Market Size and Forecast, By Distribution Channel
10.5 Europe Antipsychotic Drugs Market Size and Forecast, By Country
10.5.1 UK
10.5.2 Germany
10.5.3 France
10.5.4 Rest of Europe
11. Asia Pacific Antipsychotic Drugs Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Antipsychotic Drugs Market Share Analysis, By Therapeutic Class
11.3 Asia Pacific Antipsychotic Drugs Market Size and Forecast, By Application
11.4 Asia Pacific Antipsychotic Drugs Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Antipsychotic Drugs Market Size and Forecast, By Country
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 Rest of Asia Pacific
12 Latin America Antipsychotic Drugs Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Antipsychotic Drugs Market Share Analysis, By Therapeutic Class
12.3 Latin America Antipsychotic Drugs Market Size and Forecast, By Application
12.4 Latin America Antipsychotic Drugs Market Size and Forecast, By Distribution Channel
12.5 Latin America Antipsychotic Drugs Market Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East Antipsychotic Drugs Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Antipsychotic Drugs Market Share Analysis, By Therapeutic Class
12.3 Middle East Antipsychotic Drugs Market Size and Forecast, By Application
13.4 Middle East Antipsychotic Drugs Market Size and Forecast, By Distribution Channel
13.5 Middle East Antipsychotic Drugs Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14. Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15. Company Profiles
15.1 Eli Lily and Company
15.1. Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 AstraZeneca plc.
15.2.1. Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. GlaxoSmithKline plc.
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4. Johnson & Johnson
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5. Otsuka Pharmaceutical Co, Ltd.
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6. Pfizer Inc.
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7. Dr. Reddy's Laboratories
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us